AUTHORS: Ghadeer A. R. Y. Suaifan, Mohammed Zourob
Download as PDF
ABSTRACT: Paper-based magnetic nanoparticle biosensor for the evaluation of active PSA level was designed. This biosensing configuration is based on the detection of PSA amylodic activity using a specific peptide substrate, sandwiched between magnetic nanonanoparticles and gold sensing platform placed on the top of a paper support. Upon PSA addition, an external magnet fixed at the back of the sensor support would accelerate the cleavage of the magnetic nanoparticles-peptide moieties away from the surface. Colorimetric change from black to golden color was visualized by the naked eye. This biosensor was amenable for a qualitative and quantitative PSA detection in buffer and in spiked urine samples with a lower detection limit of 1 ng/mL and 5 ng/mL, respectively. In conclusion, the designed colorimetric biosensor pinpointed superiority in criteria's including sensitivity; simplicity and fast processing time.
KEYWORDS: Protease, Prostate Cancer, Prostate Specific Antigen, Colorimetric, Biosenser, Magnetic nano-particles
REFERENCES:
[1] Neurath, H. and K.A. Walsh, Role of proteolytic enzymes in biological regulation (a review). Proceedings of the National Academy of Sciences, 73,11, 1976, pp. 3825-3832.
[2] Woodward, J.K.L., et al., The roles of proteolytic enzymes in the development of tumour-induced bone disease in breast and prostate cancer. Bone, 41, 6, 2007, pp. 912- 927.
[3] Suaifan, G.A., et al., Proteinases As Biomarkers In Breast Cancer Prognosis And Diagnosis. Mini Reviews in Medicinal Chemistry, in press, 2016.
[4] Suaifan, G.A., S. Alhogail, and M. Zourob, Rapid and low-cost biosensor for the detection of Staphylococcus aureus. Biosensors and Bioelectronics, 90, 2017, pp. 230-237.
[5] Suaifan, G.A., S. Alhogail, and M. Zourob, Paper-based magnetic nanoparticle-peptide probe for rapid and quantitative colorimetric detection of Escherichia coli O157:H7. Biosensors and Bioelectronics, in press, 2016.
[6] Alhogail, S., G.A. Suaifan, and M. Zourob, Rapid colorimetric sensing platform for the detection of Listeria monocytogenes foodborne pathogen. Biosensors and Bioelectronics, 86, 2016, pp. 1061-6.
[7] Wignarajah, S., et al., Colorimetric Assay for the Detection of Typical Biomarkers for Periodontitis Using a Magnetic Nanoparticle Biosensor. Analytical Chemistry, 87, 24, 2015, pp. 12161-8.
[8] Sun C Fau - Su, K.-H., et al., Timeresolved single-step protease activity quantification using nanoplasmonic resonator sensors. ACS Nano, 4, 2, 2010, pp. 978-984.
[9] Wu, P., et al., Immunopeptidometric Assay for Enzymatically Active Prostate-Specific Antigen. Clinical Chemistry, 50, 1, 2004, pp. 125-129.
[10] Denmeade, S.R., et al., Specific and Efficient Peptide Substrates for Assaying the Proteolytic Activity of Prostate-specific Antigen. Cancer Research, 57, 21, 1997. pp. 4924-4930.
[11] Suaifan, G.A., et al., Recent progress in prostate-specific antigen and HIV proteases detection. Expert Reviews in Molecular Diagnostics, 13, 7, 2013, pp. 707-18.
[12] Suaifan, G.A., et al., Wash-less and highly sensitive assay for prostate specific antigen detection. Analyst, 137, 23, 2012, pp. 5614-5619.
[13] Esseghaier, C., et al., One-step assay for optical prostate specific antigen detection using magnetically engineered responsive thin film. Journal of Biomedical Nanotechnology, 10, 6, 2014, pp. 1123-9.
[14] Feng, T., et al., A graphene oxide-peptide fluorescence sensor for proteolytically active prostate-specific antigen, in Molecular BioSystems. The Royal Society of Chemistry, 2012, pp. 1441-1445.
[15] Raj, G.V., A.W. Partin, and T.J. Polascik, Clinical utility of indium 111-capromab pendetide immunoscintigraphy in the detection of early, recurrent prostate carcinoma after radical prostatectomy. Cancer, 94, 4, 2002, pp. 987-996.
[16] Sengupta, S., et al., Prostate Specific Antigen Kinetics in the Management of Prostate Cancer. The Journal of urology, 179, 3, 2008, pp. 821-826.
[17] Vessella, R.L., J. Noteboom, and P.H. Lange, Evaluation of the Abbott IMx automated immunoassay of prostatespecific antigen. Clinical Chemistry, 38, 10, 1992, pp. 2044-54.
[18] Junker, R., et al., Comparison of prostatespecific antigen (PSA) measured by four combinations of free PSA and total PSA assays. Clinical Chemistry, 43, 9, 1997, pp. 1588-1594.